Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells

International Journal of Molecular Medicine

Volumn 32, Issue 4, 2013, Pages 959-964

  Zhang, Yunjuan ^a   Owusu, Lawrence ^a   Duan, Wei ^b   Jiang, Tao ^a   Zang, Shizhu ^a   Ahmed, Ayaz ^a   Xin, Yi ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

2 dimensional gel electrophoresis; Epigallocatechin 3 gallate; Hepatocellular carcinoma; Metastasis

Indexed keywords

CELL PROTEIN; CHAPERONIN; EPIGALLOCATECHIN GALLATE; GELATIN; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 27; NUCLEOPHOSMIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CATECHIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; DNA HELICASES; DNA-BINDING PROTEINS; HEAT-SHOCK PROTEINS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS;

EID: 84883312102     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1446     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001.
2. El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999.
3. Ikai I, Yamaoka Y, Yamamoto Y, et al: Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 227: 433-439, 1998.
4. Lee JS, Chu IS, Heo J, Calvisi DF, et al: Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40: 667-676, 2004.
5. Song HY, Liu YK, Feng JT, et al: Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 132: 92-98, 2006.
6. Shukla Y: Tea and cancer chemoprevention: a comprehensive review. Asian Pacific J Cancer Prev 8: 155-165, 2007.
7. Yang CS, Wang X, Lu G and Picinich SC: Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9: 429-439, 2009.
8. Yang CS and Wang ZY: Tea and cancer. J Natl Cancer Inst 85: 1038-1049, 1993.
9. Balentine DA, Wiseman SA and Bouwens LCM: The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37: 693-704, 1997.
10. Mukhtar H and Ahmad N: Green tea in chemoprevention of cancer. Toxicol Sci 52: 111-117, 1999.
11. Singh BN, Shankar S and Srivastava RK: Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82: 1807-1821, 2011.
12. Thawonsuwan J, Kiron V, Satoh S, et al: Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss. Fish Physiol Biochem 36: 687-697, 2010.
13. Mukhtar H and Ahmad N: Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71 (Suppl 6): S1698-S1702, 2000.
14. Thangapazham RL, Singh AK, Sharma A, et al: Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245: 232-241, 2007.
15. Shankar S, Ganapathy S, Hingorani SR and Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13: 440-452, 2008.
16. Stuart EC, Scandlyn MJ and Rosengren RJ: Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci 79: 2329-2336, 2006.
17. Sen T, Moulik S, Dutta A, et al: Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 84: 194-204, 2009.
18. Lee SJ, Lee KW, Hur HJ, Chun JY, Kim SY and Lee HJ: Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-Hep-1 human hepatocellular carcinoma cells. Ann NY Acad Sci 1095: 536-544, 2007.
19. Woodhouse EC, Chuaqui RF and Liotta LC: General mechanisms of metastasis. Cancer 80 (Suppl 8): S1529-S1537, 1997.
20. Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93: 178-193, 2001.
21. Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M and Levens D: A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev 8: 465-480, 1994.
22. Zubaidah RM, Tan GS, Tan SB, Lim SG, Lin Q and Chung MC: 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics 8: 5086-5096, 2008.
23. Sanz R, Aragüés R, Stresing V, Martín B, Landemaine T, Oliva B, et al: Functional pathways shared by liver and lung metastases: a mitochondrial chaperone machine is up-regulated in soft-tissue breast cancer metastasis. Clin Exp Metastasis 24: 673-683, 2007.
24. Hansen RK, Parra I, Hilsenbeck SG, Himelstein B and Fuqua SA: Hsp27-induced MMP-9 expression in influenced by the Src tyrosine protein kinase yes. Biochem Biophys Res Commun 282: 186-193, 2001.
25. Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, et al: Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo. Br J Cancer 107: 63-70, 2012.
26. Sanna B, Debidda M, Pintus G, et al: The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway. Arch Biochem Biophys 403: 209-218, 2002.
27. Borer RA, Lehner CF, Eppenberger HM and Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56: 379-390, 1989.
28. Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, et al: Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol 28: 7050-7065, 2008.
29. Yung BY, Bor AM and Chan PK: Short exposure to actinomycin D induces 'reversible' translocation of protein B23 as well as 'reversible' inhibition of cell growth and RNA synthesis in HeLa cells. Cancer Res 50: 5987-5991, 1990.
30. Chan PK and Chan FY: A study of correlation between NPM-translocation and apoptosis in cells induced by daunomycin. Biochem Pharmacol 57: 1265-1273, 1999.
31. Herkert B, Dwertmann A, Herold S, Abed M, Naud JF, Finkernagel F, et al: The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J Cell Biol 188: 905-918, 2010.
32. Feng Y, Tian ZM, Wan MX and Zheng ZB: Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis. World J Gastroenterol 13: 2608-2614, 2007.
33. Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu W, et al: Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3: 724-737, 2003.
34. Tsai YP, Yang MH, Huang CH, et al: Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis 30: 1049?1057, 2009.